| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.068 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |